OBJECTIVES: To evaluate the feasibility and safety of head-neck cooling in conscious normal volunteers (10) and patients with medically refractory epilepsy (5) without causing shivering. PATIENTS AND METHODS: We used a non-invasive head-neck cooling system (CoolSystems Inc., Lincoln, CA, USA). The tympanic temperature (TT) and intestinal temperature (IT) were measured as two measurements of 'core temperature' (CT), and multi-site external temperatures, several physiologic variables and EEG were monitored. Seizure counts over 4-week precooling, treatment and follow-up phases were compared. RESULTS: All 15 participants completed all the cooling sessions without significant complaints. At the end of 60 min of cooling, scalp temperature fell on average by 12.2 degrees C (P < 0.001), TT by 1.67 degrees C (P < 0.001), and IT by 0.12 degrees C (P = NS). Average weekly seizure frequency decreased from 2.7 to 1.7 events per patient per week (MANOVA: P < 0.05). CONCLUSIONS: Non-invasive head-neck cooling is safe and well-tolerated. Initial pilot data in patients suggest that additional therapeutic studies are warranted.
OBJECTIVES: To evaluate the feasibility and safety of head-neck cooling in conscious normal volunteers (10) and patients with medically refractory epilepsy (5) without causing shivering. PATIENTS AND METHODS: We used a non-invasive head-neck cooling system (CoolSystems Inc., Lincoln, CA, USA). The tympanic temperature (TT) and intestinal temperature (IT) were measured as two measurements of 'core temperature' (CT), and multi-site external temperatures, several physiologic variables and EEG were monitored. Seizure counts over 4-week precooling, treatment and follow-up phases were compared. RESULTS: All 15 participants completed all the cooling sessions without significant complaints. At the end of 60 min of cooling, scalp temperature fell on average by 12.2 degrees C (P < 0.001), TT by 1.67 degrees C (P < 0.001), and IT by 0.12 degrees C (P = NS). Average weekly seizure frequency decreased from 2.7 to 1.7 events per patient per week (MANOVA: P < 0.05). CONCLUSIONS: Non-invasive head-neck cooling is safe and well-tolerated. Initial pilot data in patients suggest that additional therapeutic studies are warranted.
Authors: H Stefan; F H Lopes da Silva; W Löscher; D Schmidt; E Perucca; M J Brodie; P A J M Boon; W H Theodore; S L Moshé Journal: Acta Neurol Scand Date: 2006-03 Impact factor: 3.209
Authors: Steven R Schwid; Mary D Petrie; Ronald Murray; Jennifer Leitch; James Bowen; Alan Alquist; Richard Pelligrino; Adam Roberts; Judith Harper-Bennie; Maria Dawn Milan; Raul Guisado; Bernadette Luna; Leslie Montgomery; Richard Lamparter; Yu-Tsuan Ku; Hank Lee; Danielle Goldwater; Gary Cutter; Bruce Webbon Journal: Neurology Date: 2003-06-24 Impact factor: 9.910
Authors: Kameel M Karkar; Paul A Garcia; Lisa M Bateman; Matthew D Smyth; Nicholas M Barbaro; Mitchel Berger Journal: Epilepsia Date: 2002-08 Impact factor: 5.864
Authors: Matthew D Smyth; Rowland H Han; Chester K Yarbrough; Edward E Patterson; Xiao-Feng Yang; John W Miller; Steven M Rothman; Raimondo D'Ambrosio Journal: Ther Hypothermia Temp Manag Date: 2015-04-22 Impact factor: 1.286
Authors: William K Diprose; Catherine A Morgan; Michael Tm Wang; James P Diprose; Joanne C Lin; Sulaiman Sheriff; Doug Campbell; P Alan Barber Journal: J Cereb Blood Flow Metab Date: 2022-06-16 Impact factor: 6.960
Authors: N S Abend; A Topjian; R Ichord; S T Herman; M Helfaer; M Donnelly; V Nadkarni; D J Dlugos; R R Clancy Journal: Neurology Date: 2009-06-02 Impact factor: 9.910
Authors: Steven L Shein; Thomas Q Reynolds; Satyanarayana Gedela; Patrick M Kochanek; Michael J Bell Journal: Ther Hypothermia Temp Manag Date: 2012-09 Impact factor: 1.286
Authors: Joseph Congeni; Tamara Murray; Peyton Kline; Rachida Bouhenni; Danielle Morgan; Christopher Liebig; Alexandria Lesak; Neil L McNinch Journal: Clin J Sport Med Date: 2021-03-10 Impact factor: 3.454